European countries are experiencing a significant increase in the geriatric patient population, especially those with an age greater than 80. As per the UN Population Aging 2019 report, the number of people aged 80 or above nearly tripled from 1990 to 2019 in the world. As the geriatric population increases, the demands for healthcare services required for this group also continue to grow. The aging of an ocular surface and corneal tissues, and the consequent impairment of visual functions lead to severe eye diseases and significantly impact vision. The conditions that affect these vital parts of the eye place a critical medical and socioeconomic burden on society. Corneal transplantation is a part of keratoplasty procedures, such as endothelial keratoplasty and penetrating keratoplasty. The geriatric population is highly susceptible to Fuchs' dystrophy, a condition treated by endothelial keratoplasty (EK). In addition, bullous keratopathy occurs in older adults undergoing cataract surgeries, such as EK. Thus, the increase in the population of elderlies is driving the overall growth of the Europe corneal transplant market.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe corneal transplantation market. The Europe corneal transplantation market is expected to grow at a good CAGR during the forecast period.
The Europe corneal transplantation market is segmented based on type, indication, end user, and country. Based on type, the Europe corneal transplantation market is segmented into penetrating keratoplasty, descemet membrane endothelial keratoplasty (DMEK), descemet stripping endothelial keratoplasty (DSEK), corneal limbal stem cell transplant, and others. The penetrating keratoplasty segment dominated the Europe corneal transplantation market in 2020 and descemet membrane endothelial keratoplasty (DMEK) segment is expected to be fastest growing during forecast period. Based on indication, the Europe corneal transplantation market is segmented into fungal corneal ulcer, Fuchs dystrophy, keratoconus, keratitis, and others. The Fuchs dystrophy segment dominated the Europe corneal transplantation market in 2020 and same segment is expected to be fastest growing during forecast period. Based on end user, the Europe corneal transplantation market is segmented into hospitals, eye clinic, and ambulatory surgical centers. The hospitals segment dominated the Europe corneal transplantation market in 2020 and ambulatory surgical centers segment is expected to be fastest growing during forecast period. Based on country, the Europe corneal transplantation market has been segmented into the UK, Germany, France, Italy, Spain, and rest of Europe. Alcon Inc.; Aurolab; Cornea Biosciences, Inc.; Corneat Vision; Florida Lions Eye Bank; Keramed, Inc.; and Lifeline Scientific, Inc. are among the leading companies in the Europe corneal transplantation market.
Strategic insights for the Europe Corneal Transplantation provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 110.87 Million |
Market Size by 2028 | US$ 160.88 Million |
Global CAGR (2021 - 2028) | 5.5% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Type
|
Regions and Countries Covered | Europe
|
Market leaders and key company profiles |
The geographic scope of the Europe Corneal Transplantation refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The Europe Corneal Transplantation Market is valued at US$ 110.87 Million in 2021, it is projected to reach US$ 160.88 Million by 2028.
As per our report Europe Corneal Transplantation Market, the market size is valued at US$ 110.87 Million in 2021, projecting it to reach US$ 160.88 Million by 2028. This translates to a CAGR of approximately 5.5% during the forecast period.
The Europe Corneal Transplantation Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Corneal Transplantation Market report:
The Europe Corneal Transplantation Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Corneal Transplantation Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Corneal Transplantation Market value chain can benefit from the information contained in a comprehensive market report.